236 related articles for article (PubMed ID: 22337896)
1. Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods.
Herrmann K; Engst W; Appel KE; Monien BH; Glatt H
Mutagenesis; 2012 Jul; 27(4):453-62. PubMed ID: 22337896
[TBL] [Abstract][Full Text] [Related]
2. Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1/2.
Herrmann K; Engst W; Meinl W; Florian S; Cartus AT; Schrenk D; Appel KE; Nolden T; Himmelbauer H; Glatt H
Carcinogenesis; 2014 Apr; 35(4):935-41. PubMed ID: 24318996
[TBL] [Abstract][Full Text] [Related]
3. The effect of knockout of sulfotransferases 1a1 and 1d1 and of transgenic human sulfotransferases 1A1/1A2 on the formation of DNA adducts from furfuryl alcohol in mouse models.
Sachse B; Meinl W; Glatt H; Monien BH
Carcinogenesis; 2014 Oct; 35(10):2339-45. PubMed ID: 25053625
[TBL] [Abstract][Full Text] [Related]
4. Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels.
Tremmel R; Herrmann K; Engst W; Meinl W; Klein K; Glatt H; Zanger UM
Arch Toxicol; 2017 Oct; 91(10):3329-3339. PubMed ID: 28326452
[TBL] [Abstract][Full Text] [Related]
5. Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples.
Herrmann K; Schumacher F; Engst W; Appel KE; Klein K; Zanger UM; Glatt H
Carcinogenesis; 2013 May; 34(5):1025-30. PubMed ID: 23334163
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling.
Al-Subeihi AA; Alhusainy W; Paini A; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Food Chem Toxicol; 2013 Sep; 59():564-71. PubMed ID: 23831728
[TBL] [Abstract][Full Text] [Related]
7. Hydroxymethyl-substituted furans: mutagenicity in Salmonella typhimurium strains engineered for expression of various human and rodent sulphotransferases.
Glatt H; Schneider H; Murkovic M; Monien BH; Meinl W
Mutagenesis; 2012 Jan; 27(1):41-8. PubMed ID: 21825114
[TBL] [Abstract][Full Text] [Related]
8. Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAalphaC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes.
Glatt H; Pabel U; Meinl W; Frederiksen H; Frandsen H; Muckel E
Carcinogenesis; 2004 May; 25(5):801-7. PubMed ID: 14729582
[TBL] [Abstract][Full Text] [Related]
9. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of human sulfotransferases in the bioactivation of nitro- and aminotoluenes.
Glatt H; Sabbioni G; Monien BH; Meinl W
Environ Mol Mutagen; 2016 May; 57(4):299-311. PubMed ID: 26924705
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation.
Cartus AT; Herrmann K; Weishaupt LW; Merz KH; Engst W; Glatt H; Schrenk D
Toxicol Sci; 2012 Sep; 129(1):21-34. PubMed ID: 22610610
[TBL] [Abstract][Full Text] [Related]
11. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of furfuryl alcohol: formation of 2-methylfuranyl DNA adducts in Salmonella typhimurium strains expressing human sulfotransferase 1A1 and in FVB/N mice.
Monien BH; Herrmann K; Florian S; Glatt H
Carcinogenesis; 2011 Oct; 32(10):1533-9. PubMed ID: 21729924
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection of multiple DNA adducts in human lung samples by isotope-dilution UPLC-MS/MS.
Monien BH; Schumacher F; Herrmann K; Glatt H; Turesky RJ; Chesné C
Anal Chem; 2015 Jan; 87(1):641-8. PubMed ID: 25423194
[TBL] [Abstract][Full Text] [Related]
14. Detection of DNA adducts originating from 1-methoxy-3-indolylmethyl glucosinolate using isotope-dilution UPLC-ESI-MS/MS.
Schumacher F; Engst W; Monien BH; Florian S; Schnapper A; Steinhauser L; Albert K; Frank H; Seidel A; Glatt H
Anal Chem; 2012 Jul; 84(14):6256-62. PubMed ID: 22816785
[TBL] [Abstract][Full Text] [Related]
15. Highly selective bioactivation of 1- and 2-hydroxy-3-methylcholanthrene to mutagens by individual human and other mammalian sulphotransferases expressed in Salmonella typhimurium.
Meinl W; Tsoi C; Swedmark S; Tibbs ZE; Falany CN; Glatt H
Mutagenesis; 2013 Sep; 28(5):609-19. PubMed ID: 23894158
[TBL] [Abstract][Full Text] [Related]
16. Comparative investigation of the mutagenicity of propenylic and allylic asarone isomers in the Ames fluctuation assay.
Berg K; Bischoff R; Stegmüller S; Cartus A; Schrenk D
Mutagenesis; 2016 Jul; 31(4):443-51. PubMed ID: 26895844
[TBL] [Abstract][Full Text] [Related]
17. Formation of DNA Adducts by 1-Methoxy-3-indolylmethylalcohol, a Breakdown Product of a Glucosinolate, in the Mouse: Impact of the SULT1A1 Status-Wild-Type, Knockout or Humanised.
Glatt H; Weißenberg SY; Ehlers A; Lampen A; Seidel A; Schumacher F; Engst W; Meinl W
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612635
[TBL] [Abstract][Full Text] [Related]
18. Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity.
Glatt H; Meinl W
Carcinogenesis; 2004 May; 25(5):779-86. PubMed ID: 14754874
[TBL] [Abstract][Full Text] [Related]
19. Determination of sulfotransferase forms involved in the metabolic activation of the genotoxicant 1-hydroxymethylpyrene using bacterially expressed enzymes and genetically modified mouse models.
Bendadani C; Meinl W; Monien B; Dobbernack G; Florian S; Engst W; Nolden T; Himmelbauer H; Glatt H
Chem Res Toxicol; 2014 Jun; 27(6):1060-9. PubMed ID: 24802129
[TBL] [Abstract][Full Text] [Related]
20. Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue.
Meinl W; Pabel U; Osterloh-Quiroz M; Hengstler JG; Glatt H
Int J Cancer; 2006 Mar; 118(5):1090-7. PubMed ID: 16161050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
